insights_auto
Why is LKFT down 2.77%?
Dive Deeperchevron_right
LKFT:AMS
Lakefront Biotherapeutics NV
€30.18
arrow_downward
-2.77%(-0.86) 1D
Nov 13, 5:35:35 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LKFT...
Open
€30.96
High
€31.10
Low
€30.00
Mkt. cap
2.10B
Avg. vol.
85.62K
Volume
63.83K
52-wk high
€32.00
52-wk low
€22.32
No. of employees
196
Open
€30.96
High
€31.10
Low
€30.00
Mkt. cap
2.10B
Avg. vol.
85.62K
Volume
63.83K
52-wk high
€32.00
52-wk low
€22.32
No. of employees
196
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Stock market today: Dow, S&P 500, Nasdaq futures edge higher after wholesale inflation grows, Nvidia stock rebounds
Nasdaq
·
1 day ago
Chartstopper: November 13, 2026
Bloomberg.com
·
17 hours ago
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV
CEOPaul Stoffels | Paul Stoffels
Employees196
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitelakefrontbio.com